The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Ductal adenocarcinoma of the prostate is a rare histologic variant of prostate cancer that often presents with normal prostate-specific antigen levels and is inherently aggressive enough to spread beyond the prostate gland. Here, we describe a case of prostatic ductal adenocarcinoma that formed a mass in the retrovesical space and presented with a high prostate-specific antigen level.
To determine whether angiotensin II type 1 receptor (AT1R) expression and tumor angiogenesis in human bladder cancer (BCa) specimens acquired by transurethral resection (TUR). It has recently been reported that AT1R is expressed in several tumors and is involved in tumor angiogenesis. However, no study has investigated AT1R expression in association with angiogenesis in clinical specimens of bladder...
To evaluate the recurrence and progression in patients with non-muscle–invasive bladder tumors who remained tumor-free for at least 5 years, which should assist in the development of schedules of their follow-up evaluations. Non-muscle–invasive bladder tumors that recur or progress at a late time point are not rare.Between 1985 and 2002, 814 cases diagnosed with non-muscle–invasive bladder cancer...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.